Current Report Filing (8-k)
April 29 2021 - 10:57AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
______________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): April 24, 2021
______________
HEALTHTECH SOLUTIONS, INC.
(Exact name of registrant as specified in its
charter)
______________
Utah
|
0-51012
|
84-2528660
|
(State or Other Jurisdiction
|
(Commission
|
(I.R.S. Employer
|
of Incorporation)
|
File Number)
|
Identification No.)
|
90 Broad Street, 16th Floor, New York,
New York 10004
(Address of Principal Executive Office) (Zip
Code)
844-926-3399
(Registrant’s telephone number, including
area code)
Securities registered pursuant to Section
12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
|
|
|
|
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
ITEM 5.02 DEPARTURE OF DIRECTORS
OR CERTAIN OFFICERS
On April 24, 2021 Denis Kleinfeld resigned from his
position as a member of the Registrant's Board of Directors.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
|
Healthtech Solutions, Inc.
|
|
|
|
Date: April 29, 2021
|
By:
|
/s/ David Rubin
David Rubin, Chief Executive Officer
|
HealthTech Solutions (CE) (USOTC:HLTT)
Historical Stock Chart
From Feb 2024 to Mar 2024
HealthTech Solutions (CE) (USOTC:HLTT)
Historical Stock Chart
From Mar 2023 to Mar 2024